Iain McGill, Founder of Quell Therapeutics

Iain McGill is the founder of Quell Therapeutics. Quell Therapeutics has raised $344M in total funding. Latest round: Series B.

About Iain McGill

Iain McGill is the Co-founder and CEO of Quell Therapeutics, a biotechnology company developing engineered T-regulatory (Treg) cell therapies for autoimmune diseases and organ transplant rejection. He announced the company's Series A expansion to approximately $84 million, which became the largest Series A in the Treg cell therapy space. McGill leads Quell's clinical pipeline, which includes one active clinical trial as of recent reports.

Iain McGill at a glance

More founders in London, United Kingdom (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library